Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersAllergy Physician in Henrico, VA
NPI: 1063521904Primary Practice Location
Richmond Allergy and Asthma Specialists,PC
9920 Independence Park Dr, Henrico, VA
Primary Employer
Richmond Allergy and Asthma Specialists,PC
richmondallergy.com
HQ Phone
Get M.D. Robert's Phone Numberphone_androidMobile
Get M.D. Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardVA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 124 | 143 |
| 2 | 95165Preparation and provision of single or multiple antigens for allergen immunotherapy | 102 | 1,740 |
| 3 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 43 | 47 |
| 4 | 95115Injection of incremental dosages of allergen | 42 | 588 |
| 5 | 95117Injection of incremental dosages of allergen, 2 or more injections | 41 | 675 |
Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study.
Authors: Eduardo Tschen, Adelaide Hebert, Leon Kircik
Publication Date: 2016-05-20
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
Authors: Mary Spellman, Eduardo Tschen, Lawrence Eichenfield, Linda Stein Gold, Adelaide Hebert
Publication Date: 2017-10
Authors: Willey, T M, Bagge-Hansen, M, Lee, J R I, Call, R, Landt, L, van Buuren, T, Colesniuc, C, Monton, C, Valmianski, I, Schuller, Ivan K
Journal: J Chem Phys
Lead Sponsor: COUR Pharmaceutical Development Company, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: CNP-201
Lead Sponsor: Incyte Corporation
Intervention / Treatment: DRUG: Vehicle cream, DRUG: Ruxolitinib cream
Lead Sponsor: Oneness Biotech Co., Ltd.
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: FB825
